The SBIR and STTR programs were reauthorized on April 13, 2026. Currently, NIH has no active SBIR or STTR Notices of Funding Opportunity (NOFOs). Future NOFOs are forecasted at Grants.gov prior to opening for applications. The next standard receipt date is September 5, 2026.

Meet NCI SBIR at the BIO Investor Forum

October 17 – October 18, 2023

San Francisco, CA

Add to Outlook Calendar

If you are a cancer technology innovator attending the BIO Investor Forum, don’t miss the chance to meet with NCI SBIR. Program Director Xing-Jian Lou, PhD will be available to discuss how NCI SBIR funding opportunities and resources can support your cancer technology commercialization journey.